the-lancet-infectious-diseases
The Lancet Infectious Diseases (the-lancet-infectious-diseases)
Journal positioning
The Lancet Infectious Diseases is one of the most influential specialty journals in the Lancet family, published by Elsevier. It publishes high-impact clinical, epidemiological, and public-health research across all aspects of infectious diseases—bacterial, viral, parasitic, and fungal infections; antimicrobial resistance; vaccines; outbreak science; and health-systems responses to infectious threats. The journal maintains Lancet family editorial standards: pre-registration, CONSORT compliance, global-health equity framing, and a bias toward findings that change clinical practice, public-health policy, or infectious-disease control at population scale. Research that is methodologically competent but locally contained, descriptive without actionable implications, or focused on a narrow pathogen without broader significance will not meet the bar.
This skill is a fit / venue-selection / re-framing tool. It does not replace the journal's current official submission guidelines. Before submitting, re-check the live author instructions on the Lancet/Elsevier site or submission system.
When to trigger
- The author names The Lancet Infectious Diseases as the target venue for a clinical trial, outbreak investigation, vaccine efficacy study, or AMR epidemiology analysis.
- A manuscript on infectious disease has global-health or public-health policy implications and needs framing for the Lancet family editorial culture.
- A vaccine, antimicrobial, or antiviral trial has phase III results that could influence WHO or national immunisation or treatment guidelines.
- The author needs the journal's desk-reject risks and credible alternatives before submitting.